HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinghe Mao Selected Research

Antigens

1/2013The C-terminal common to group 3 POTES (CtG3P): a newly discovered nucleolar marker associated with malignant progression and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinghe Mao Research Topics

Disease

4Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2012
2Neoplasms (Cancer)
10/2014 - 01/2013
2Neoplasm Metastasis (Metastasis)
01/2013 - 02/2012
1Hepatocellular Carcinoma (Hepatoma)
07/2020
1Insulin Resistance
01/2013
1Type 2 Diabetes Mellitus (MODY)
01/2013
1Testicular Neoplasms (Testicular Cancer)
01/2013
1Renal Cell Carcinoma (Grawitz Tumor)
07/2004
1Hypoxia (Hypoxemia)
07/2004

Drug/Important Bio-Agent (IBA)

3LipidsIBA
12/2021 - 01/2012
3Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2012
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2020
1Fatty Acids (Saturated Fatty Acids)IBA
11/2019
1Sphingosine-1-Phosphate ReceptorsIBA
10/2014
1Proteins (Proteins, Gene)FDA Link
01/2013
1AntigensIBA
01/2013
1Biological ProductsIBA
01/2013
1nucleolar organizer region associated proteinsIBA
01/2013
1ElementsIBA
01/2013
1Nonesterified Fatty Acids (NEFA)IBA
01/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1P-2 (P 2)IBA
02/2012
11-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA
02/2012
1Ether (Diethyl Ether)IBA
01/2012
1phosphatidylethanolamineIBA
01/2012
1erucylphosphocholineIBA
01/2012
1Phosphatidylcholines (Phosphatidylcholine)IBA
01/2012
1Fibronectins (Fibronectin)IBA
07/2004
1UbiquitinIBA
07/2004

Therapy/Procedure

1Prostatectomy (Retropubic Prostatectomy)
02/2012